Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response.
Katodritou
Eirini
E
Ganz
Tomas
T
Terpos
Evangelos
E
Verrou
Evgenia
E
Olbina
Gordana
G
Gastari
Vassiliki
V
Hadjiaggelidou
Christina
C
Varthaliti
Maria
M
Georgiadou
Sofia
S
Westerman
Mark
M
Zervas
Konstantinos
K
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood* / Q000139:chemically induced; D023181:Antimicrobial Cationic Peptides / Q000097:blood*; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D015331:Cohort Studies; D005260:Female; D064451:Hepcidins; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D007501:Iron / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy*
D023181:Antimicrobial Cationic Peptides; D015415:Biomarkers; D001798:Blood Proteins; C578702:HAMP protein, human; D064451:Hepcidins; D007155:Immunologic Factors; D007501:Iron